Annual CAPEX
$230.40 M
+$91.60 M+65.99%
31 December 2023
Summary:
United Therapeutics annual capital expenditures is currently $230.40 million, with the most recent change of +$91.60 million (+65.99%) on 31 December 2023. During the last 3 years, it has risen by +$171.10 million (+288.53%). UTHR annual CAPEX is now at all-time high.UTHR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$76.50 M
+$31.40 M+69.62%
30 September 2024
Summary:
United Therapeutics quarterly capital expenditures is currently $76.50 million, with the most recent change of +$31.40 million (+69.62%) on 30 September 2024. Over the past year, it has increased by +$10.80 million (+16.44%). UTHR quarterly CAPEX is now -2.80% below its all-time high of $78.70 million, reached on 31 December 2023.UTHR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$238.50 M
+$10.80 M+4.74%
30 September 2024
Summary:
United Therapeutics TTM capital expenditures is currently $238.50 million, with the most recent change of +$10.80 million (+4.74%) on 30 September 2024. Over the past year, it has increased by +$47.30 million (+24.74%). UTHR TTM CAPEX is now at all-time high.UTHR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.0% | +16.4% | +24.7% |
| 3 y3 years | +288.5% | +228.3% | +281.6% |
| 5 y5 years | +24.9% | +462.5% | +115.3% |
UTHR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +288.5% | -2.8% | +466.7% | at high | +281.6% |
| 5 y | 5 years | at high | +288.5% | -2.8% | +621.7% | at high | +333.6% |
| alltime | all time | at high | >+9999.0% | -2.8% | >+9999.0% | at high | >+9999.0% |
United Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $76.50 M(+69.6%) | $238.50 M(+4.7%) |
| June 2024 | - | $45.10 M(+18.1%) | $227.70 M(+0.2%) |
| Mar 2024 | - | $38.20 M(-51.5%) | $227.30 M(-1.3%) |
| Dec 2023 | $230.40 M(+66.0%) | $78.70 M(+19.8%) | $230.40 M(+20.5%) |
| Sept 2023 | - | $65.70 M(+47.0%) | $191.20 M(-1.6%) |
| June 2023 | - | $44.70 M(+8.2%) | $194.30 M(+16.6%) |
| Mar 2023 | - | $41.30 M(+4.6%) | $166.60 M(+20.0%) |
| Dec 2022 | $138.80 M(+14.9%) | $39.50 M(-42.6%) | $138.80 M(-18.3%) |
| Sept 2022 | - | $68.80 M(+304.7%) | $169.90 M(+36.6%) |
| June 2022 | - | $17.00 M(+25.9%) | $124.40 M(+0.6%) |
| Mar 2022 | - | $13.50 M(-80.9%) | $123.70 M(+2.4%) |
| Dec 2021 | $120.80 M(+103.7%) | $70.60 M(+203.0%) | $120.80 M(+93.3%) |
| Sept 2021 | - | $23.30 M(+42.9%) | $62.50 M(+13.6%) |
| June 2021 | - | $16.30 M(+53.8%) | $55.00 M(-3.3%) |
| Mar 2021 | - | $10.60 M(-13.8%) | $56.90 M(-4.0%) |
| Dec 2020 | $59.30 M(-29.2%) | $12.30 M(-22.2%) | $59.30 M(-17.3%) |
| Sept 2020 | - | $15.80 M(-13.2%) | $71.70 M(+3.2%) |
| June 2020 | - | $18.20 M(+40.0%) | $69.50 M(-2.9%) |
| Mar 2020 | - | $13.00 M(-47.4%) | $71.60 M(-14.5%) |
| Dec 2019 | $83.70 M(-54.6%) | $24.70 M(+81.6%) | $83.70 M(-24.5%) |
| Sept 2019 | - | $13.60 M(-33.0%) | $110.80 M(-20.1%) |
| June 2019 | - | $20.30 M(-19.1%) | $138.70 M(-19.3%) |
| Mar 2019 | - | $25.10 M(-51.5%) | $171.90 M(-6.8%) |
| Dec 2018 | $184.40 M(+113.7%) | $51.80 M(+24.8%) | $184.40 M(+15.0%) |
| Sept 2018 | - | $41.50 M(-22.4%) | $160.40 M(+13.8%) |
| June 2018 | - | $53.50 M(+42.3%) | $140.90 M(+30.1%) |
| Mar 2018 | - | $37.60 M(+35.3%) | $108.30 M(+25.5%) |
| Dec 2017 | $86.30 M(+127.1%) | $27.80 M(+26.4%) | $86.30 M(+26.9%) |
| Sept 2017 | - | $22.00 M(+5.3%) | $68.00 M(+23.4%) |
| June 2017 | - | $20.90 M(+34.0%) | $55.10 M(+23.5%) |
| Mar 2017 | - | $15.60 M(+64.2%) | $44.60 M(+17.4%) |
| Dec 2016 | $38.00 M(-23.7%) | $9.50 M(+4.4%) | $38.00 M(-36.7%) |
| Sept 2016 | - | $9.10 M(-12.5%) | $60.00 M(-2.3%) |
| June 2016 | - | $10.40 M(+15.6%) | $61.40 M(+12.0%) |
| Mar 2016 | - | $9.00 M(-71.4%) | $54.80 M(+10.0%) |
| Dec 2015 | $49.80 M(+5.1%) | $31.50 M(+200.0%) | $49.80 M(+142.4%) |
| Sept 2015 | - | $10.50 M(+176.3%) | $20.54 M(-13.3%) |
| June 2015 | - | $3.80 M(-5.0%) | $23.69 M(-27.6%) |
| Mar 2015 | - | $4.00 M(+78.3%) | $32.72 M(-31.0%) |
| Dec 2014 | $47.40 M(+48.5%) | $2.24 M(-83.6%) | $47.40 M(-19.1%) |
| Sept 2014 | - | $13.64 M(+6.3%) | $58.57 M(+7.8%) |
| June 2014 | - | $12.84 M(-31.3%) | $54.34 M(+17.3%) |
| Mar 2014 | - | $18.68 M(+39.2%) | $46.34 M(+45.2%) |
| Dec 2013 | $31.91 M(-71.5%) | $13.41 M(+42.4%) | $31.91 M(-19.7%) |
| Sept 2013 | - | $9.42 M(+94.7%) | $39.75 M(+7.2%) |
| June 2013 | - | $4.84 M(+14.0%) | $37.06 M(-51.1%) |
| Mar 2013 | - | $4.24 M(-80.0%) | $75.87 M(-32.2%) |
| Dec 2012 | $111.91 M(+211.0%) | $21.25 M(+215.8%) | $111.91 M(+24.5%) |
| Sept 2012 | - | $6.73 M(-84.6%) | $89.90 M(-11.0%) |
| June 2012 | - | $43.64 M(+8.3%) | $101.02 M(+44.5%) |
| Mar 2012 | - | $40.28 M(-5492.5%) | $69.92 M(+94.4%) |
| Dec 2011 | $35.98 M | -$747.00 K(-104.2%) | $35.98 M(-14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $17.84 M(+42.2%) | $42.17 M(+48.4%) |
| June 2011 | - | $12.55 M(+98.0%) | $28.41 M(+52.6%) |
| Mar 2011 | - | $6.34 M(+16.4%) | $18.61 M(-0.1%) |
| Dec 2010 | $18.64 M(-80.5%) | $5.44 M(+33.3%) | $18.64 M(-46.3%) |
| Sept 2010 | - | $4.08 M(+48.2%) | $34.71 M(-36.5%) |
| June 2010 | - | $2.75 M(-56.7%) | $54.68 M(-32.1%) |
| Mar 2010 | - | $6.36 M(-70.4%) | $80.49 M(-15.6%) |
| Dec 2009 | $95.40 M(-23.3%) | $21.51 M(-10.6%) | $95.40 M(-13.6%) |
| Sept 2009 | - | $24.06 M(-15.8%) | $110.45 M(-13.3%) |
| June 2009 | - | $28.57 M(+34.3%) | $127.35 M(-3.9%) |
| Mar 2009 | - | $21.27 M(-41.8%) | $132.49 M(+6.5%) |
| Dec 2008 | $124.42 M(+221.8%) | $36.56 M(-10.7%) | $124.42 M(+17.0%) |
| Sept 2008 | - | $40.95 M(+21.5%) | $106.37 M(+46.3%) |
| June 2008 | - | $33.71 M(+155.5%) | $72.72 M(+66.0%) |
| Mar 2008 | - | $13.19 M(-28.7%) | $43.81 M(+13.3%) |
| Dec 2007 | $38.66 M(+147.3%) | $18.51 M(+153.5%) | $38.66 M(+70.1%) |
| Sept 2007 | - | $7.30 M(+52.1%) | $22.72 M(+16.4%) |
| June 2007 | - | $4.80 M(-40.3%) | $19.52 M(-13.5%) |
| Mar 2007 | - | $8.04 M(+212.2%) | $22.57 M(+44.4%) |
| Dec 2006 | $15.63 M(+155.6%) | $2.58 M(-37.1%) | $15.63 M(+4.1%) |
| Sept 2006 | - | $4.10 M(-47.8%) | $15.02 M(+31.4%) |
| June 2006 | - | $7.85 M(+609.4%) | $11.43 M(+68.5%) |
| Mar 2006 | - | $1.11 M(-43.4%) | $6.78 M(+10.9%) |
| Dec 2005 | $6.12 M(+17.3%) | $1.96 M(+283.7%) | $6.12 M(+20.4%) |
| Sept 2005 | - | $510.00 K(-84.1%) | $5.08 M(-2.3%) |
| June 2005 | - | $3.21 M(+627.7%) | $5.20 M(+0.2%) |
| Mar 2005 | - | $441.00 K(-52.2%) | $5.19 M(-0.4%) |
| Dec 2004 | $5.22 M(-25.5%) | $922.00 K(+45.9%) | $5.22 M(-38.7%) |
| Sept 2004 | - | $632.00 K(-80.2%) | $8.51 M(+0.7%) |
| June 2004 | - | $3.20 M(+589.4%) | $8.44 M(+31.8%) |
| Mar 2004 | - | $464.00 K(-89.0%) | $6.41 M(-8.5%) |
| Dec 2003 | $7.00 M(+95.6%) | $4.21 M(+638.8%) | $7.00 M(+87.8%) |
| Sept 2003 | - | $570.00 K(-50.9%) | $3.73 M(-27.8%) |
| June 2003 | - | $1.16 M(+9.5%) | $5.17 M(+23.9%) |
| Mar 2003 | - | $1.06 M(+13.2%) | $4.17 M(+16.4%) |
| Dec 2002 | $3.58 M(+421.3%) | $937.00 K(-53.3%) | $3.58 M(+23.7%) |
| Sept 2002 | - | $2.01 M(+1123.8%) | $2.90 M(+191.5%) |
| June 2002 | - | $164.00 K(-65.3%) | $993.30 K(+2.7%) |
| Mar 2002 | - | $473.00 K(+88.1%) | $966.90 K(+40.7%) |
| Dec 2001 | $687.00 K(+7.4%) | $251.40 K(+139.7%) | $687.00 K(-3.6%) |
| Sept 2001 | - | $104.90 K(-23.8%) | $712.60 K(+2.4%) |
| June 2001 | - | $137.60 K(-28.7%) | $695.90 K(+3.0%) |
| Mar 2001 | - | $193.10 K(-30.3%) | $675.60 K(+5.6%) |
| Dec 2000 | $639.90 K(-72.2%) | $277.00 K(+214.1%) | $639.90 K(-16.1%) |
| Sept 2000 | - | $88.20 K(-24.8%) | $762.90 K(-66.5%) |
| June 2000 | - | $117.30 K(-25.5%) | $2.27 M(-3.5%) |
| Mar 2000 | - | $157.40 K(-60.7%) | $2.36 M(+2.5%) |
| Dec 1999 | $2.30 M(+130.0%) | $400.00 K(-75.0%) | $2.30 M(+21.1%) |
| Sept 1999 | - | $1.60 M(+700.0%) | $1.90 M(+533.3%) |
| June 1999 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Mar 1999 | - | $100.00 K | $100.00 K |
| Dec 1998 | $1.00 M | - | - |
FAQ
- What is United Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for United Therapeutics?
- What is United Therapeutics annual CAPEX year-on-year change?
- What is United Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for United Therapeutics?
- What is United Therapeutics quarterly CAPEX year-on-year change?
- What is United Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for United Therapeutics?
- What is United Therapeutics TTM CAPEX year-on-year change?
What is United Therapeutics annual capital expenditures?
The current annual CAPEX of UTHR is $230.40 M
What is the all time high annual CAPEX for United Therapeutics?
United Therapeutics all-time high annual capital expenditures is $230.40 M
What is United Therapeutics annual CAPEX year-on-year change?
Over the past year, UTHR annual capital expenditures has changed by +$91.60 M (+65.99%)
What is United Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of UTHR is $76.50 M
What is the all time high quarterly CAPEX for United Therapeutics?
United Therapeutics all-time high quarterly capital expenditures is $78.70 M
What is United Therapeutics quarterly CAPEX year-on-year change?
Over the past year, UTHR quarterly capital expenditures has changed by +$10.80 M (+16.44%)
What is United Therapeutics TTM capital expenditures?
The current TTM CAPEX of UTHR is $238.50 M
What is the all time high TTM CAPEX for United Therapeutics?
United Therapeutics all-time high TTM capital expenditures is $238.50 M
What is United Therapeutics TTM CAPEX year-on-year change?
Over the past year, UTHR TTM capital expenditures has changed by +$47.30 M (+24.74%)